Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Daratumumab in Combination with Bortezomib, Thalidomide, and Dexamethasone Regimens in Newly Diagnosed Multiple Myeloma with Renal Insufficiency in Real-World: A Non-Interventional Prospective Multicenter Observational Study

Chengcheng Fu, Jing Wang, Lingzhi Yan, Song Jin, Jingjing Shang, Xiaolan Shi, Weiqin Yao, Zhi Yan, Mingqing Zhu, De-Pei Wu

Blood (2023) 142 (Supplement 1): 6691.

https://doi.org/10.1182/blood-2023-185362

Published: 2023

Journal Articles

Haploidentical Hematopoietic Cell Transplantation Combined with an Unrelated Cord Blood Unit for Adult Acute Myeloid Leukemia Results in Improved Survival Compared to Haploidentical Hematopoietic Cell Transplantation: Results of a Multicenter, Randomized, Phase III Trial

Biqi Zhou, Jia Chen, Tianhui Liu, Yanming Zhang, Yishan Ye, Yiyang Ding, Mingqing Zhu, Xiao Ma, Xiaoli Li, Zhihong Lin, He Huang, Yang Xu, Depei Wu

Blood (2023) 142 (Supplement 1): 1041.

https://doi.org/10.1182/blood-2023-180993

Published: 2023

Journal Articles

Does Detection of <20% Lymphoblasts in Patients with CML Herald Imminent Blast Crisis? a Study from BCR::ABL1 Pathology Group

Blood (2023) 142 (Supplement 1): 6364.

https://doi.org/10.1182/blood-2023-187020

Published: 2023

Journal Articles

All-Trans-Retinoic Acid Induction Overcomes Immune Evasion through Downregulating Immune Checkpoint Molecules and Inducing a Cytokine Storm Triggered By Overexpression of S100A8/A9 Signaling

Blood (2023) 142 (Supplement 1): 4335.

https://doi.org/10.1182/blood-2023-184432

Published: 2023

Journal Articles

Venetoclax with decitabine as frontline treatment in younger adults with newly diagnosed ELN adverse-risk AML

Blood (2023) 142 (15): 1323–1327.

https://doi.org/10.1182/blood.2023020102

Published: 2023

Includes: Supplemental data

Journal Articles

Comparison of Next-Generation Flow Cytometry (NGF) and Next-Generation Sequencing (NGS) in the Assessment of Minimal Residual Disease in Multiple Myeloma

Qingqing Wang, Li Yao, Mingqing Zhu, Lingzhi Yan, Song Jin, Jingjing Shang, Xiaolan Shi, Yingying Zhai, Shuang Yan, Weiqin Yao, You Hongying, Depei Wu, Chengcheng Fu

Blood (2022) 140 (Supplement 1): 7249–7250.

https://doi.org/10.1182/blood-2022-157270

Published: 2022

Journal Articles

HLA-Mismatched Stem Cell Microtransplantation Compared to Matched-Sibling Donor Transplantation for Acute Myeloid Leukemia in First Complete Remission

Limin Liu, Huiying Qiu, XiaoWen Tang, MD, Yue Han, MD, Miao Miao, Chengcheng Fu, Zhengming Jin, Mingqing Zhu, Depei Wu, MD PhD

Blood (2016) 128 (22): 5842.

https://doi.org/10.1182/blood.V128.22.5842.5842

Published: 2016

Journal Articles

Exome Sequencing Identifies Highly Recurrent Somatic GATA2 and CEBPA Mutations in Acute Erythroid Leukemia

Suning Chen, Nana Ping, Jia Yin, Wenxiu Cheng, Qinrong Wang, Qian Wang, Liang Ma, Hong Yao, Lijun Wen, Yang Xu, Hong Liu, Zhengming Jin, Mingqing Zhu, Jianying Liang, Dandan Liu, Huiying Qiu, Aining Sun, PhD, Changgeng Ruan, MD PhD, Wu Depei, MD

Blood (2015) 126 (23): 1394.

https://doi.org/10.1182/blood.V126.23.1394.1394

Published: 2015

Journal Articles

Efficacy of Immunomodulatory Therapy with All-Trans Retinoid Acid for Adults with Chronic Immune Thrombocytopenia

Lan Dai, Zhaoyue Wang, MD, Ri Zhang, MD, PhD, Xia Bai, MD, Mingqing Zhu, Changgeng Ruan, MD, PhD

Blood (2012) 120 (21): 3335.

https://doi.org/10.1182/blood.V120.21.3335.3335

Published: 2012

Journal Articles

Minimal Residual Disease Status at Day +100 Post Allogeneic Hematopoietic Stem Cell Transplantation Is a Powerful Predictor for Post-Transplant Outcome In Patients with High Risk Acute Leukemia

XiaoWen Tang, MD, Xingwei Sun, Shengli Xue, Xiaolan Shi, Mingqing Zhu, Wenhong Shen, Li Chen, Aining Sun, Wu Depei, MD, PhD

Blood (2010) 116 (21): 3550.

https://doi.org/10.1182/blood.V116.21.3550.3550

Published: 2010

Journal Articles

A Biotin-Avidin-EL ISA for Studying on Platelet Membrane Surface P-Selectin and Its Clinical Application

Yiming Zhao, Youtao Zhang, Shiqi Lu, Mingqing Zhu, Yang He, Changgeng Ruan, MD, PhD

Blood (2010) 116 (21): 5132.

https://doi.org/10.1182/blood.V116.21.5132.5132

Published: 2010

Journal Articles

Clinical, Biological Profile and Outcome of Biphenotypic Acute Leukemia: a Case Series.

Yanming Zhang, Wu Depei, MD, PhD, Aining Sun, Huiying Qiu, Guangsheng He, Zhengming Jin, Xiaowen Tang, Miao Miao, Chengcheng Fu, Yue Han, Mingqing Zhu, Yongquan Xue, Zixing Chen, Changgeng Ruan, MD, PhD

Blood (2010) 116 (21): 1683.

https://doi.org/10.1182/blood.V116.21.1683.1683

Published: 2010

Journal Articles

Changes of Intracellular Signal Pathway of mTOR/S6 in T Cells of Refractory/Relapsed Aplastic Anemia

Guangsheng He, Xiang Zhang, Wu Depei, Mingqing Zhu, Aining Sun

Blood (2008) 112 (11): 4110.

https://doi.org/10.1182/blood.V112.11.4110.4110

Published: 2008

Journal Articles

Changes of Intracellular Signal Pathway of mTOR/S6 in T Cells of Low-Risk Myelodysplastic Syndromes

Xiang Zhang, Guangsheng He, Wu Depei, Mingqing Zhu, Aining Sun

Blood (2008) 112 (11): 4588.

https://doi.org/10.1182/blood.V112.11.4588.4588

Published: 2008

Journal Articles

CD3 − cd(16+56) + Cell Dose Is An Important Factor Determining Clinical Outcomes in Patients Undergoing Unmanipulated HLA-Identical Sibling Hematopoietic Stem Cell Transplantation

Xiaowen Tang, Biyun Peng, Mingqing Zhu, Wu Depei, Aining Sun, Changgeng Ruan

Blood (2008) 112 (11): 4384.

https://doi.org/10.1182/blood.V112.11.4384.4384

Published: 2008

NARROW

Efficacy and Safety of Daratumumab in Combination with Bortezomib, Thalidomide, and Dexamethasone Regimens in Newly Diagnosed Multiple Myeloma with Renal Insufficiency in Real-World: A Non-Interventional Prospective Multicenter Observational Study

Haploidentical Hematopoietic Cell Transplantation Combined with an Unrelated Cord Blood Unit for Adult Acute Myeloid Leukemia Results in Improved Survival Compared to Haploidentical Hematopoietic Cell Transplantation: Results of a Multicenter, Randomized, Phase III Trial

Does Detection of <20% Lymphoblasts in Patients with CML Herald Imminent Blast Crisis? a Study from BCR::ABL1 Pathology Group

All-Trans-Retinoic Acid Induction Overcomes Immune Evasion through Downregulating Immune Checkpoint Molecules and Inducing a Cytokine Storm Triggered By Overexpression of S100A8/A9 Signaling

Venetoclax with decitabine as frontline treatment in younger adults with newly diagnosed ELN adverse-risk AML

Comparison of Next-Generation Flow Cytometry (NGF) and Next-Generation Sequencing (NGS) in the Assessment of Minimal Residual Disease in Multiple Myeloma

HLA-Mismatched Stem Cell Microtransplantation Compared to Matched-Sibling Donor Transplantation for Acute Myeloid Leukemia in First Complete Remission

Exome Sequencing Identifies Highly Recurrent Somatic GATA2 and CEBPA Mutations in Acute Erythroid Leukemia

Efficacy of Immunomodulatory Therapy with All-Trans Retinoid Acid for Adults with Chronic Immune Thrombocytopenia

Minimal Residual Disease Status at Day +100 Post Allogeneic Hematopoietic Stem Cell Transplantation Is a Powerful Predictor for Post-Transplant Outcome In Patients with High Risk Acute Leukemia

A Biotin-Avidin-EL ISA for Studying on Platelet Membrane Surface P-Selectin and Its Clinical Application

Clinical, Biological Profile and Outcome of Biphenotypic Acute Leukemia: a Case Series.

Changes of Intracellular Signal Pathway of mTOR/S6 in T Cells of Refractory/Relapsed Aplastic Anemia

Changes of Intracellular Signal Pathway of mTOR/S6 in T Cells of Low-Risk Myelodysplastic Syndromes

CD3 − cd(16+56) + Cell Dose Is An Important Factor Determining Clinical Outcomes in Patients Undergoing Unmanipulated HLA-Identical Sibling Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only